Exome Asset Management LLC Legend Biotech Corp Transaction History
Exome Asset Management LLC
- $133 Billion
- Q4 2024
A detailed history of Exome Asset Management LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Exome Asset Management LLC holds 37,600 shares of LEGN stock, worth $1.39 Million. This represents 0.92% of its overall portfolio holdings.
Number of Shares
37,600
Previous 47,000
20.0%
Holding current value
$1.39 Million
Previous $2.29 Billion
46.58%
% of portfolio
0.92%
Previous 1.55%
Shares
3 transactions
Others Institutions Holding LEGN
# of Institutions
231Shares Held
86MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$278 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$252 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$221 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$212 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$211 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.19B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...